RhumbLine Advisers’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,337
| Closed | -$2.48K | – | 4423 |
|
|
2023
Q2 | $2.48K | Sell |
8,337
-59,916
| -88% | -$17.9K | ﹤0.01% | 4185 |
|
|
2023
Q1 | $29K | Buy |
68,253
+782
| +1% | +$332 | ﹤0.01% | 2926 |
|
|
2022
Q4 | $80K | Buy |
67,471
+21,937
| +48% | +$26K | ﹤0.01% | 2918 |
|
|
2022
Q3 | $106K | Buy |
45,534
+32,493
| +249% | +$75.6K | ﹤0.01% | 2997 |
|
|
2022
Q2 | $29K | Buy |
+13,041
| New | +$29K | ﹤0.01% | 3072 |
|